Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|33|1|72-72

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.33, Iss.1, 2018-01, pp. : 72-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 335-338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten Years and Counting: Moving Leucine‐Rich RepeatKinase 2 Inhibitors to the Clinic

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 2, 2015-02 ,pp. : 180-189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long‐Standing Model

By  

BRAIN PATHOLOGY, Vol. 25, Iss. 4, 2015-07 ,pp. : 377-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cognitive profile of LRRK2‐related Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 5, 2015-04 ,pp. : 728-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

The small leucine‐rich repeat proteoglycans in tissue repair and atherosclerosis

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 278, Iss. 5, 2015-11 ,pp. : 447-461

John Wiley & Sons Inc

Access to resources Recommend Favorite